Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2002;91:577-584
Published online before print September 12, 2002, doi: 10.1161/01.RES.0000036901.58329.D7
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
91/7/577    most recent
01.RES.0000036901.58329.D7v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lardenoye, J.H.P.
Right arrow Articles by Quax, P.H.A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lardenoye, J.H.P.
Right arrow Articles by Quax, P.H.A.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Substance via MeSH
*Genetics Home Reference
Related Collections
Right arrow Restenosis
Right arrow Animal models of human disease
Right arrow Genetically altered mice
Right arrow CV surgery: other
Right arrow Mechanism of atherosclerosis/growth factors
(Circulation Research. 2002;91:577.)
© 2002 American Heart Association, Inc.


Molecular Medicine

Accelerated Atherosclerosis and Calcification in Vein Grafts

A Study in APOE*3 Leiden Transgenic Mice

J.H.P. Lardenoye, M.R. de Vries, C.W.G.M. Löwik, Q. Xu, C.R. Dhore, J.P.M. Cleutjens, V.W.M. van Hinsbergh, J.H. van Bockel, P.H.A. Quax

From the Gaubius Laboratory TNO-PG (J.H.P.L., M.R.d.V., V.W.M.v.H., P.H.A.Q.), Leiden, the Netherlands; Leiden University Medical Center (J.H.P.L., C.W.G.M.L., J.H.v.B.), Leiden, The Netherlands; The Institute for Biomedical Aging Research (Q.X.), Innsbruck, Austria; and the Department of Pathology (C.R.D., J.P.M.C.), Cardiovascular Research Institute Maastricht, University of Maastricht, The Netherlands.

Correspondence to Dr P.H.A. Quax, Gaubius Laboratory TNO-PG, PO Box 2215, 2301 CE Leiden, The Netherlands. E-mail PHA.Quax{at}pg.tno.nl

Vein grafts fail due to development of intimal hyperplasia and accelerated atherosclerosis. Many murine genetic models in which genes are overexpressed, deleted, or mutated have been introduced recently. Therefore, mouse models are very well suited to dissect the relative contribution of different genes in the development of accelerated atherosclerosis. In the present study, we evaluated whether accelerated atherosclerosis in human vein grafts could be mimicked in hypercholesterolemic APOE*3 Leiden transgenic mice. Venous bypass grafting was performed in the carotid artery in APOE*3 Leiden mice fed either a standard chow diet or a high cholesterol–rich diet for 4 weeks. At several time points (0 hour to 28 days), mice were euthanized and the morphology of the vein grafts was analyzed. In normocholesterolemic mice, vein graft thickening up to 10-fold original thickness, predominantly consisting of {alpha}-smooth muscle cell actin–positive cells, was observed after 28 days. In hypercholesterolemic mice, accelerated atherosclerosis with accumulation of lipid-loaded foam cells was observed within 7 days after surgery. This accelerated atherosclerosis progressed in time and resulted in significant increase in vein graft thickening up to 50 times original thickness with foam cell–rich lesions and calcification within 28 days after surgery. The atherosclerotic lesions observed in these murine grafts show high morphological resemblance with the atherosclerotic lesions observed in human vein grafts. This accelerated, diet-dependent induction of atherosclerotic-like lesions in murine vein grafts provides a valuable tool in evaluating the mechanisms of accelerated atherosclerosis and therapeutic interventions of vein graft disease.


Key Words: vein graft • mice • accelerated atherosclerosis




This article has been cited by other articles:


Home page
Asian Cardiovasc. Thorac. Ann.Home page
S.-A. Hassantash, B. Bikdeli, S. Kalantarian, M. Sadeghian, and H. Afshar
Pathophysiology of Aortocoronary Saphenous Vein Bypass Graft Disease
Asian Cardiovasc Thorac Ann, August 1, 2008; 16(4): 331 - 336.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. Schepers, M.R. de Vries, C.J. van Leuven, J.M. Grimbergen, V.M. Holers, M.R. Daha, J.H. van Bockel, and P.H.A. Quax
Inhibition of Complement Component C3 Reduces Vein Graft Atherosclerosis in Apolipoprotein E3-Leiden Transgenic Mice
Circulation, December 19, 2006; 114(25): 2831 - 2838.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. Schepers, D. Eefting, P.I. Bonta, J.M. Grimbergen, M.R. de Vries, V. van Weel, C.J. de Vries, K. Egashira, J.H. van Bockel, and P.H.A. Quax
Anti-MCP-1 Gene Therapy Inhibits Vascular Smooth Muscle Cells Proliferation and Attenuates Vein Graft Thickening Both In Vitro and In Vivo
Arterioscler. Thromb. Vasc. Biol., September 1, 2006; 26(9): 2063 - 2069.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
G.D.M. Collett and A.E. Canfield
Angiogenesis and Pericytes in the Initiation of Ectopic Calcification
Circ. Res., May 13, 2005; 96(9): 930 - 938.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
Q. Xu, M. Sata, and R. Nagai
Mouse Models of Vein Grafts
Arterioscler. Thromb. Vasc. Biol., November 1, 2004; 24(11): e185 - e187.
[Full Text] [PDF]


Home page
Circ. Res.Home page
M. Abedin, Y. Tintut, and L. L. Demer
Mesenchymal Stem Cells and the Artery Wall
Circ. Res., October 1, 2004; 95(7): 671 - 676.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
Q. Xu
Mouse Models of Arteriosclerosis: From Arterial Injuries to Vascular Grafts
Am. J. Pathol., July 1, 2004; 165(1): 1 - 10.
[Abstract] [Full Text] [PDF]